Skip to main content
Figure 5 | Breast Cancer Research

Figure 5

From: Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis

Figure 5

Breast cancer patients with autoantibodies to MUC1 glycopeptide combinational subset show increased time to metastasis. A, metastasis free survival with patients with autoantibodies versus no auto-antibodies (P = 0.08). B, metastasis free survival of patients with strong autoantibodies versus no antibodies (P = 0.032). C, overall survival of patients with strong autoantibodies versus no antibodies. Thick lines indicate no auto-antibodies in sera. Dotted lines indicate autoantibodies. Vertical dashes indicate censored events.

Back to article page